JAEB CENTER FOR HEALTH RESEARCH INC: Form 990, tax year 2023

View the entire original 990 at ProPublica ↗

Organization
JAEB CENTER FOR HEALTH RESEARCH INC (EIN 59-3187624)
Tax period
2023-01-01 to 2023-12-31
Filed
2024-04-05
IRS object ID
202430969349301203
Schema version
2023v5.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2024-04-05T10:17:37-05:00ReturnTs
Tax Period End2023-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN410746749PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1CLIFTONLARSONALLEN LLPBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line1420 SOUTH ORANGE AVENUE SUITE 900AddressLine1Txt
CityORLANDOCityNm
State AbbreviationFLStateAbbreviationCd
ZIP32801ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2023-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN593187624EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1JAEB CENTER FOR HEALTH RESEARCHBusinessNameLine1Txt
Business Name Line2FOUNDATION INCBusinessNameLine2Txt
FieldValueIRS element (for citing)
Business Name ControlJAEBBusinessNameControlTxt
Phone8139758690PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line115310 AMBERLY DRIVE 350AddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33647ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonERICA VOGTPersonNm
Person TitleTREASURERPersonTitleTxt
Phone8139758690PhoneNum
Signature2024-04-02SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstERICAPersonFirstNm
Person LastVOGTPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN
FieldValueIRS element (for citing)
IRS Responsible Prty Info CurrYes (1)IRSResponsiblePrtyInfoCurrInd

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonTINA HENTONPreparerPersonNm
PTINP00630282PTIN
Phone4078021200PhoneNum
Preparation2024-04-02PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer3TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2023TaxYr
Build TS2023-04-26 12:10:37ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerADAM GLASSMANPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line115310 AMBERLY DRIVE 350AddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33647ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$55,500,575GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.JAEB.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1998FormationYr
Legal Domicile StateFLLegalDomicileStateCd
Activity Or MissionDESIGN AND CONDUCT WORLD-CLASS CLINICAL TRIALS AND EPIDEMIOLOGIC RESEARCH.ActivityOrMissionDesc
Voting Members Governing Body5VotingMembersGoverningBodyCnt
Voting Members Independent4VotingMembersIndependentCnt
Total Employee165TotalEmployeeCnt
Total Volunteers4TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$28,983,474PYContributionsGrantsAmt
CY Contributions Grants$35,083,784CYContributionsGrantsAmt
PY Program Service Revenue$8,818,282PYProgramServiceRevenueAmt
CY Program Service Revenue$17,927,381CYProgramServiceRevenueAmt
PY Investment Income$5,171PYInvestmentIncomeAmt
CY Investment Income$209,814CYInvestmentIncomeAmt
PY Other Revenue$0PYOtherRevenueAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$37,806,927PYTotalRevenueAmt
CY Total Revenue$53,220,979CYTotalRevenueAmt
PY Grants And Similar Paid$3,161PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$911,714CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$17,020,908PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$18,429,062CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$0CYTotalFundraisingExpenseAmt
PY Other Expenses$17,312,640PYOtherExpensesAmt
CY Other Expenses$25,547,640CYOtherExpensesAmt
PY Total Expenses$34,336,709PYTotalExpensesAmt
CY Total Expenses$44,888,416CYTotalExpensesAmt
PY Revenues Less Expenses$3,470,218PYRevenuesLessExpensesAmt
CY Revenues Less Expenses$8,332,563CYRevenuesLessExpensesAmt
Total Assets BOY$10,449,118TotalAssetsBOYAmt
Total Assets EOY$23,767,716TotalAssetsEOYAmt
Total Liabilities BOY$14,538,729TotalLiabilitiesBOYAmt
Total Liabilities EOY$19,487,316TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY-$4,089,611NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$4,280,400NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionOUR MISSION IS TO EXPAND SCIENTIFIC KNOWLEDGE AND IMPROVE PUBLIC HEALTH BY DESIGNING AND CONDUCTING WORLD-CLASS CLINICAL TRIALS AND EPIDEMIOLOGIC RESEARCH.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$37,585,083ExpenseAmt
Grant$911,714GrantAmt
Revenue$17,927,381RevenueAmt
DescSEE SCHEDULE O DURING 2023, JCHR WAS ENGAGED IN 53 CLINICAL STUDIES. THESE STUDIES RESULTED IN 42 SCIENTIFIC PUBLICATIONS AND 59 PRESENTATIONS AT NATIONAL AND INTERNATIONAL MEETINGS.IN 2023, JCHR RECEIVED GRANTS FROM THE NATIONAL INSTITUTES OF HEALTH (8), HELMSLEY CHARITABLE TRUST (8), JDRF (6), FOUNDATION FIGHTING BLINDNESS (5), CYSTIC FIBROSIS FOUNDATION (4), AND FOOD AND DRUG ADMINISTRATION (1). COLLABORATIONS WITH INDUSTRY CONTINUE TO FORM AN INTEGRAL PART OF OUR BUSINESS. JCHR WAS ENGAGED IN STRATEGIC COLLABORATIONS WITH 10 INDUSTRY PARTNERS IN 2023. THESE COLLABORATIONS SPANNED 15 STUDIES. SEVERAL STUDIES ARE FUNDED BY MULTIPLE SOURCES. FOR EXAMPLE, ONE CLINICAL TRIAL EVALUATING FENOFIBRATE FOR DIABETIC RETINOPATHY IS A LARGE COLLABORATION WITH FUNDS PROVIDED BY THE NATIONAL INSTITUTES OF HEALTH (NATIONAL EYE INSTITUTE AND NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASE), JDRF, HELMSLEY CHARITABLE TRUST, AND ROCHE. JCHR ALSO SELF-FUNDED TWO STUDIES AND NUMEROUS STATISTICAL ANALYSIS PROJECTS USING DATASETS FROM PREVIOUSLY COMPLETED STUDIES. AMONG 2,894 ENTITIES RECEIVING NIH FUNDING IN 2023, JCHR RANKS IN THE TOP 8 PERCENT. OUT OF 66,149 NIH GRANTS PROVIDED IN 2023, JCHR HAD THE 136TH- (TOP 0.2 PERCENT) AND 210TH- (TOP 0.3 PERCENT) LARGEST GRANTS (SOURCE: BLUE RIDGE INSTITUTE FOR MEDICAL RESEARCH, 2023).IN 2023, THE JCHR COORDINATED RANDOMIZED TRIAL OF A BIONIC PANCREAS IN INDIVIDUALS WITH TYPE 1 DIABETES LEAD TO FDA 510(K) CLEARANCE FOR THE BETA BIONICS ILET BIONIC PANCREAS. IN ADDITION, RESULTS FROM THE DEXCOM SPONSORED MOBILE STUDY (COORDINATED BY JCHR) SERVED AS THE PRIMARY PIECE OF CLINICAL EVIDENCE THAT LED TO MEDICARE COVERAGE EXPANSION FOR CONTINUOUS GLUCOSE MONITORS, PROVIDING COVERAGE TO PEOPLE WITH DIABETES USING INSULIN, IRRESPECTIVE OF DIABETES TYPE.RESULTS FROM JCHR-AUTHORED MANUSCRIPTS INCLUDE THE FOLLOWING TWO THAT WERE PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE AND THREE PUBLISHED IN JAMA:A STUDY INVOLVING PREGNANT WOMEN WITH TYPE 1 DIABETES COMPARED THE EFFECTIVENESS OF STANDARD INSULIN THERAPY TO HYBRID CLOSED-LOOP THERAPY, WHICH USES CONTINUOUS GLUCOSE MONITORING. THE RESULTS SHOWED THAT THE CLOSED-LOOP THERAPY GROUP HAD SIGNIFICANTLY BETTER GLYCEMIC CONTROL DURING PREGNANCY COMPARED WITH THE STANDARD-CARE GROUP, WITH FEWER INSTANCES OF HYPERGLYCEMIA AND IMPROVED OVERNIGHT GLUCOSE LEVELS, INDICATING THE POTENTIAL BENEFITS OF THIS APPROACH FOR MANAGING TYPE 1 DIABETES DURING PREGNANCY.IN A 13-WEEK TRIAL INVOLVING YOUNG CHILDREN (AGED 2 TO UNDER 6 YEARS) WITH TYPE 1 DIABETES, A CLOSED-LOOP SYSTEM OF INSULIN DELIVERY WAS COMPARED WITH STANDARD CARE USING EITHER AN INSULIN PUMP OR MULTIPLE DAILY INJECTIONS WITH A CONTINUOUS GLUCOSE MONITOR. RESULTS SHOWED THAT CHILDREN USING THE CLOSED-LOOP SYSTEM SPENT SIGNIFICANTLY MORE TIME WITHIN THE TARGET RANGE COMPARED WITH THOSE IN THE STANDARD-CARE GROUP.IN A DOUBLE-BLIND, RANDOMIZED CLINICAL TRIAL INVOLVING CHILDREN AND ADOLESCENTS NEWLY DIAGNOSED WITH TYPE 1 DIABETES, THE EFFECTS OF VERAPAMIL, A CALCIUM CHANNEL BLOCKER, WERE INVESTIGATED ON PANCREATIC BETA CELL FUNCTION. PARTICIPANTS RECEIVING VERAPAMIL DEMONSTRATED A 30 PERCENT HIGHER C-PEPTIDE LEVEL AT 52 WEEKS COMPARED WITH THOSE ON A PLACEBO, INDICATING PARTIAL PRESERVATION OF PANCREATIC BETA CELL FUNCTION. FURTHER STUDIES ARE NEEDED TO ASSESS THE LONG-TERM DURABILITY OF C-PEPTIDE IMPROVEMENT AND DETERMINE THE OPTIMAL DURATION OF THERAPY. IN A RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL INVOLVING YOUTH WITH NEWLY DIAGNOSED TYPE 1 DIABETES, INTENSIVE DIABETES MANAGEMENT, INCLUDING THE USE OF AN AUTOMATED INSULIN DELIVERY SYSTEM, WAS COMPARED TO STANDARD CARE. THE STUDY AIMED TO DETERMINE IF ACHIEVING NEAR NORMALIZATION OF GLUCOSE LEVELS IMMEDIATELY AFTER DIAGNOSIS COULD PRESERVE PANCREATIC BETA CELL FUNCTION. DESPITE ACHIEVING EXCELLENT GLUCOSE CONTROL, THE INTENSIVE MANAGEMENT GROUP DID NOT SHOW A SIGNIFICANT DIFFERENCE IN PANCREATIC C-PEPTIDE SECRETION DECLINE AT 52 WEEKS COMPARED TO THE STANDARD CARE GROUP, SUGGESTING THAT THIS APPROACH DID NOT IMPACT THE PRESERVATION OF BETA CELL FUNCTION IN THE STUDIED POPULATION.A STUDY COMPARING INTRAVITREAL AFLIBERCEPT TREATMENT TO A SHAM PROCEDURE IN INDIVIDUALS WITH MODERATE TO SEVERE NONPROLIFERATIVE DIABETIC RETINOPATHY (NPDR) WITHOUT CENTER-INVOLVED DIABETIC MACULAR EDEMA (CI-DME) REVEALED THAT OVER FOUR YEARS, AFLIBERCEPT SIGNIFICANTLY REDUCED THE LIKELIHOOD OF DEVELOPING VISION-THREATENING COMPLICATIONS COMPARED TO THE SHAM PROCEDURE. HOWEVER, DESPITE ANATOMICAL IMPROVEMENT, THERE WAS NO SIGNIFICANT DIFFERENCE IN VISUAL ACUITY BETWEEN THE TWO GROUPS. THE STUDY SUGGESTS THAT USING AFLIBERCEPT PREVENTIVELY IN PATIENTS WITH NPDR WITHOUT CI-DME MAY NOT BE GENERALLY NECESSARY BASED ON THE OBSERVED OUTCOMES.JCHR'S INVOLVEMENT IN DIABETES STUDIES CONTINUES TO EXPAND AS IT SOLIDIFIED ITS REPUTATION AS THE PREMIERE COORDINATING CENTER WORLDWIDE FOR DIABETES DEVICE STUDIES.Desc
Total Program Service Expenses$37,585,083TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other Assets0ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (1)ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To Org0MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash Contri0DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related EntityYes (1)RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document103IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (1)BackupWthldComplianceInd
Employee165EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members5GoverningBodyVotingMembersCnt
Independent Voting Member4IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org DocumentsYes (1)ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of Committees0MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention PolicyYes (1)DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process OtherYes (1)CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1ERICA VOGTBusinessNameLine1Txt
FieldValueIRS element (for citing)
Phone8139758690PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line115310 AMBERLY DRIVE STE 350AddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33647ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (13 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtIndividual Trustee Or DirectorIndividualTrusteeOrDirectorIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtOfficerOfficerIndKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeInd
ROY BECK
MEDICAL DIRECTOR (PRESIDENT THRU 09/23)40.001.00Yes (X)$486,749$0$87,294
DANA BALL
DIRECTOR1.001.00Yes (X)$0$0$0
NEIL BRESSLER
DIRECTOR1.001.00Yes (X)$0$0$0
ANNE LINDBLAD
DIRECTOR1.001.00Yes (X)$0$0$0
SHAN SHIKARPURI
DIRECTOR1.001.00Yes (X)$0$0$0
ERICA VOGT
CHIEF FINANCIAL OFFICER40.001.00$221,629$0$17,165Yes (X)
ADAM GLASSMAN
PRESIDENT (EXECTIVE DIRECTOR THRU 09/23)40.001.00$332,525$0$44,515Yes (X)
JEANNIE PERKINS
CHIEF RESEARCH COMPLIANCE OFFICER40.000.00$190,500$0$20,643Yes (X)
CRAIG KOLLMAN
DIRECTOR OF BIOSTATISTICS40.000.00$243,094$0$39,684Yes (X)
ALLISON AYALA
BIOSTATISTICIAN IV40.000.00$185,529$0$19,331Yes (X)
B MICHELE MELIA
BIOSTATISTICIAN V40.000.00$224,250$0$19,884Yes (X)
PETER CALHOUN
BIOSTATISTICIAN IV40.000.00$202,727$0$19,780Yes (X)
RAYMOND KRAKER
EPIDEMIOLOGIST IV40.000.00$168,949$0$39,681Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,255,952TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$307,977TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K76IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
NOTAL VISION INC
7717 COPPERMINE DRIVEMANASSASVA20109AI SERVICES, SOFTWARE SERVICES, DEVICE R$1,607,457
JOSLIN DIABETES CENTER
1 JOSLIN PLACEBOSTONMA02215PATIENT-FACING RESEARCH SERVICES$567,000
MAYO CLINIC
PO BOX 860334ROCHESTERMN55486PATIENT-FACING RESEARCH SERVICES$483,825
DUKE UNIVERSITY
PO BOX 602651CHARLOTTENC28260READING CENTER SERVICES, PATIENT-FACING$442,628
UNIVERSITY OF COLORADO DENVER
PO BOX 910238DENVERCO80291PATIENT-FACING RESEARCH SERVICES$430,498
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K60CntrctRcvdGreaterThan100KCnt
Related Organizations$6,177,957RelatedOrganizationsAmt
Government Grants$18,644,335GovernmentGrantsAmt
All Other Contributions$10,261,492AllOtherContributionsAmt
Total Contributions$35,083,784TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescINDUSTRY PROGRAM SERVICE EXCHANGEDesc
Business541700BusinessCd
Total Revenue Column$17,927,381TotalRevenueColumnAmt
Related Or Exempt Func Income$17,927,381RelatedOrExemptFuncIncomeAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$17,927,381TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$206,410TotalRevenueColumnAmt
Exclusion$206,410ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$2,283,000SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$2,279,596SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$3,404SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$3,404TotalRevenueColumnAmt
Exclusion$3,404ExclusionAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$53,220,979TotalRevenueColumnAmt
Related Or Exempt Func Income$17,927,381RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$209,814ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$911,714TotalAmt
Program Services$911,714ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$1,401,020TotalAmt
Program Services$412,463ProgramServicesAmt
Management And General$988,557ManagementAndGeneralAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$12,636,855TotalAmt
Program Services$9,409,039ProgramServicesAmt
Management And General$3,227,816ManagementAndGeneralAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$1,950,641TotalAmt
Program Services$1,395,712ProgramServicesAmt
Management And General$554,929ManagementAndGeneralAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$1,341,277TotalAmt
Program Services$979,772ProgramServicesAmt
Management And General$361,505ManagementAndGeneralAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$1,099,269TotalAmt
Program Services$773,683ProgramServicesAmt
Management And General$325,586ManagementAndGeneralAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$25,187TotalAmt
Management And General$25,187ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$125,887TotalAmt
Management And General$125,887ManagementAndGeneralAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$3,813TotalAmt
Management And General$3,813ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$1,040,420TotalAmt
Program Services$933,222ProgramServicesAmt
Management And General$107,198ManagementAndGeneralAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$1,202TotalAmt
Management And General$1,202ManagementAndGeneralAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$32,360TotalAmt
Management And General$32,360ManagementAndGeneralAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$651,967TotalAmt
Program Services$1,152ProgramServicesAmt
Management And General$650,815ManagementAndGeneralAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$507,952TotalAmt
Management And General$507,952ManagementAndGeneralAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$1,000,683TotalAmt
Program Services$964,533ProgramServicesAmt
Management And General$36,150ManagementAndGeneralAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$109,083TotalAmt
Management And General$109,083ManagementAndGeneralAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$135,013TotalAmt
Management And General$135,013ManagementAndGeneralAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtManagement And GeneralManagementAndGeneralAmt
SUBCONTRACTOR PAYMENTS$18,433,305$18,433,305
RESEARCH EXPENSES$3,321,200$3,321,200
TRAINING$53,457$1,350$52,107
DUES & SUBSCRIPTIONS$37,697$37,697

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$68,414TotalAmt
Program Services$47,938ProgramServicesAmt
Management And General$20,476ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$44,888,416TotalAmt
Program Services$37,585,083ProgramServicesAmt
Management And General$7,303,333ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$4,590,445BOYAmt
EOY$9,063,779EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$2,633,881EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$5,073,199BOYAmt
EOY$7,699,495EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$12,138EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$183,416BOYAmt
EOY$464,581EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$1,280,054LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$1,041,604LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$149,921BOYAmt
EOY$238,450EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$2,574,929EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$452,137BOYAmt
EOY$1,080,463EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$10,449,118BOYAmt
EOY$23,767,716EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$1,406,415BOYAmt
EOY$4,597,583EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$12,707,254BOYAmt
EOY$13,768,197EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$425,060BOYAmt
EOY$1,121,536EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$14,538,729BOYAmt
EOY$19,487,316EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY-$4,089,611BOYAmt
EOY$4,280,400EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY-$4,089,611BOYAmt
EOY$4,280,400EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$10,449,118BOYAmt
EOY$23,767,716EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss$8,332,563ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$37,448NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets$0OtherChangesInNetAssetsAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS AuditedYes (1)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (1)AuditCommitteeInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$28,232,464CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$31,738,886CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$24,875,930CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$28,983,474CurrentTaxYearMinus1YearAmt
Current Tax Year$35,083,784CurrentTaxYearAmt
Total$148,914,538TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$28,232,464CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$31,738,886CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$24,875,930CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$28,983,474CurrentTaxYearMinus1YearAmt
Current Tax Year$35,083,784CurrentTaxYearAmt
Total$148,914,538TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$13,288,696SubstantialContributorsTotAmt
Public Support Total170$135,625,842PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$219,897CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$59,752CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$2,389CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$5,171CurrentTaxYearMinus1YearAmt
Current Tax Year$206,410CurrentTaxYearAmt
Total$493,619TotalAmt
FieldValueIRS element (for citing)
Total Support$149,408,157TotalSupportAmt
Gross Receipts Rltd Activities$41,671,296GrossReceiptsRltdActivitiesAmt
Public Support CY1700.90780PublicSupportCY170Pct
Public Support PY1700.85860PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$78,047OtherCostOrOtherBasisAmt
Book Value$78,047BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$1,202,007OtherCostOrOtherBasisAmt
Depreciation$1,041,604DepreciationAmt
Book Value$160,403BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$238,450TotalBookValueLandBuildingsAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescLEASE LIABILITYDesc
Amt$1,121,536Amt
FieldValueIRS element (for citing)
Total Liability$1,121,536TotalLiabilityAmt

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (3 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
NORTH AMERICA03PROGRAM SERVICESCLINICAL RESEARCH SITES CONTRACTED TO ENROLL PATIENTS AND CONDUCT RESEARCH ACTIVITIES$46,656
EUROPE (INCLUDING ICELAND & GREENLAND)04PROGRAM SERVICESCLINICAL RESEARCH SITES CONTRACTED TO ENROLL PATIENTS AND CONDUCT RESEARCH ACTIVITIES$153,123
MIDDLE EAST AND NORTH AFRICA01PROGRAM SERVICESCLINICAL RESEARCH SITES CONTRACTED TO ENROLL PATIENTS AND CONDUCT RESEARCH ACTIVITIES$13,980
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees8SubtotalEmployeesCnt
Continuation Total Office0ContinuationTotalOfficeCnt
Continuation Total Employee0ContinuationTotalEmployeeCnt
Total Office0TotalOfficeCnt
Total Employee8TotalEmployeeCnt
Subtotal Spent$213,759SubtotalSpentAmt
Continuation Spent$0ContinuationSpentAmt
Total Spent$213,759TotalSpentAmt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable

Recipient Business Name RecipientBusinessName

FieldValueIRS element (for citing)
Business Name Line1JAEB CENTER RESEARCH TRUST INCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line115310 AMBERLY DRIVEAddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33647ZIPCd
FieldValueIRS element (for citing)
Recipient EIN270717710RecipientEIN
IRC Section501(C)(3)IRCSectionDesc
Cash Grant$911,714CashGrantAmt
Non Cash Assistance$0NonCashAssistanceAmt
Valuation Method UsedN/AValuationMethodUsedDesc
Non Cash AssistanceN/ANonCashAssistanceDesc
Purpose Of GrantGENERAL SUPPORTPurposeOfGrantTxt
FieldValueIRS element (for citing)
Total501c3 Org1Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2:FormAndLineReferenceDesc
ExplanationJCHR MADE GRANTS ONLY TO ITS OWN RELATED ORGANIZATION.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (9 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
ROY BECK
MEDICAL DIRECTOR (PRESIDENT THRU 09/$486,749$0$0$0$0$0$22,838$0$64,456$0$574,043$0$0$0
ADAM GLASSMAN
PRESIDENT (EXECTIVE DIRECTOR THRU 09$332,525$0$0$0$0$0$15,000$0$29,515$0$377,040$0$0$0
CRAIG KOLLMAN
DIRECTOR OF BIOSTATISTICS$243,094$0$0$0$0$0$11,250$0$28,434$0$282,778$0$0$0
B MICHELE MELIA
BIOSTATISTICIAN V$224,250$0$0$0$0$0$9,713$0$10,171$0$244,134$0$0$0
ERICA VOGT
CHIEF FINANCIAL OFFICER$221,629$0$0$0$0$0$9,500$0$7,665$0$238,794$0$0$0
PETER CALHOUN
BIOSTATISTICIAN IV$202,727$0$0$0$0$0$9,250$0$10,530$0$222,507$0$0$0
JEANNIE PERKINS
CHIEF RESEARCH COMPLIANCE OFFICER$190,500$0$0$0$0$0$8,400$0$12,243$0$211,143$0$0$0
RAYMOND KRAKER
EPIDEMIOLOGIST IV$168,949$0$0$0$0$0$8,300$0$31,381$0$208,630$0$0$0
ALLISON AYALA
BIOSTATISTICIAN IV$185,529$0$0$0$0$0$8,150$0$11,181$0$204,860$0$0$0

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 3FormAndLineReferenceDesc
ExplanationTHE BOARD OF DIRECTORS SHALL ANNUALLY REVIEW AND APPROVE THE COMPENSATION OF THE CORPORATE OFFICERS, ANY KEY EMPLOYEES (AS DEFINED BY THE IRS), AND THE NEXT FIVE HIGHEST COMPENSATED EMPLOYEES AS LISTED ON THE ORGANIZATION'S PRIOR YEAR FORM 990. IT IS THE BOARD'S INTENTION THAT THIS POLICY AND ITS ASSOCIATED PROCEDURES WILL MEET THE REBUTTABLE PRESUMPTION TEST UNDER IRC 4958 AND TREASURY REGULATION 53.4958-6. THE PURPOSE OF THE ANNUAL REVIEW IS TO ENSURE THAT THE COMPENSATION PROGRAM FALLS WITHIN A REASONABLE RANGE OF COMPETITIVE PRACTICES FOR COMPARABLE POSITIONS AMONG SIMILARLY SITUATED ORGANIZATIONS. THE BOARD WILL KEEP ROBUST MINUTES OF ITS DELIBERATIONS AND DECISIONS, THE PRESIDENT'S REPORTS, THE CORPORATE TREASURER'S REPORTS, AND ANY OTHER SUPPORTING DOCUMENTATION THAT IT RELIES ON FOR ITS COMPENSATION DECISIONS. ALL THESE DOCUMENTS WILL BE DELIVERED TO THE CORPORATE SECRETARY PROMPTLY AFTER THE BOARD MEETING FOR ENTRY INTO THE CORPORATE BOOKS AND RECORDS.ExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (6 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
FORM 990, PART VI, SECTION A, LINE 4THE ORGANIZATION'S ARTICLES OF INCORPORATION AND BYLAWS WERE UPDATED IN 2023.
FORM 990, PART VI, SECTION A, LINE 8BTHERE ARE NO COMMITTEES WITH AUTHORITY TO ACT ON BEHALF OF THE GOVERNING BODY.
FORM 990, PART VI, SECTION B, LINE 11BTHE BOARD OF DIRECTORS REVIEWS AND APPROVES FORM 990 PRIOR TO THE FORM'S FILING.
FORM 990, PART VI, SECTION B, LINE 12CANY BOARD DIRECTOR, CORPORATE OFFICER, OR MEMBER OF A BOARD COMMITTEE WHO HAS DIRECT OR INDIRECT FINANCIAL INTEREST, AS DEFINED BELOW, IS AN INTERESTED PERSON. IF A PERSON IS AN INTERESTED PERSON WITH RESPECT TO ANY AFFILIATE OR SUBSIDIARY OF THE CORPORATION, HE/SHE IS AN INTERESTED PERSON WITH RESPECT TO THE CORPORATION AND ALL AFFILIATED OR SUBSIDIARY ENTITIES. A CONFLICT OF INTEREST SHALL BE DEEMED TO EXIST AT ANY TIME WHEN AN INTEREST HELD, INCLUDING WITHOUT LIMITATION A FINANCIAL INTEREST, OR RELATIONSHIP MAINTAINED BY AN INTERESTED PERSON, PROHIBITS OR INHIBITS, OR POTENTIALLY PROHIBITS OR INHIBITS, THE INTERESTED PERSON FROM EXERCISING INDEPENDENT JUDGMENT IN THE BEST INTERESTS OF THE CORPORATION. A CONFLICT OF INTEREST SHALL NOT EXIST IF RESULTING SOLELY FROM THE NORMAL CONDUCT OF ACTIVITIES AND BUSINESS BY AND BETWEEN THE CORPORATION OR OTHER AFFILIATES OF THE CORPORATION. AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF THE FACTS AND CIRCUMSTANCES OF ANY CONFLICT OF INTEREST OR CONFLICT OF LOYALTY TO THE APPROPRIATE GOVERNANCE BODY WITH RESPECT TO ANY ACTION OR PROPOSED ACTION THAT GIVES RISE TO A CONFLICT OF INTEREST OR CONFLICT OF LOYALTY. DISCLOSURE MUST BE MADE TO THE BOARD OF DIRECTORS OR THE BOARD OF DIRECTORS COMMITTEE AS APPROPRIATE TO THE CIRCUMSTANCES. AFTER DISCLOSURE OF THE CONFLICT OF INTEREST OR CONFLICT OF LOYALTY AND ALL MATERIAL FACTS RELATED THERETO, AND AFTER ANY DISCUSSION WITH THE INTERESTED PERSON, THE INTERESTED PERSON SHALL LEAVE ANY BOARD OF DIRECTORS OR COMMITTEE MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD DIRECTORS OR COMMITTEE MEMBERS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. IN THE CASE OF A DISCLOSURE TO A COMMITTEE, THE COMMITTEE MAY REFER THE MATTER FOR DECISION TO THE BOARD OF DIRECTORS. PENDING REVIEW AND RESOLUTION BY THE BOARD OF DIRECTORS OR BOARD COMMITTEE, THE INTERESTED PERSON SHALL LEAVE DURING ANY DELIBERATIONS OR ACTION CONCERNING THE MATTER THAT GIVES RISE TO A CONFLICT OF INTEREST.
FORM 990, PART VI, SECTION B, LINE 15THE BOARD OF DIRECTORS SHALL ANNUALLY REVIEW AND APPROVE THE COMPENSATION OF THE CORPORATE OFFICERS, ANY KEY EMPLOYEES (AS DEFINED BY THE IRS), AND THE NEXT FIVE HIGHEST COMPENSATED EMPLOYEES AS LISTED ON THE ORGANIZATION'S PRIOR YEAR FORM 990. IT IS THE BOARD'S INTENTION THAT THIS POLICY AND ITS ASSOCIATED PROCEDURES WILL MEET THE REBUTTABLE PRESUMPTION TEST UNDER IRC 4958 AND TREASURY REGULATION 53.4958-6. THE PURPOSE OF THE ANNUAL REVIEW IS TO ENSURE THAT THE COMPENSATION PROGRAM FALLS WITHIN A REASONABLE RANGE OF COMPETITIVE PRACTICES FOR COMPARABLE POSITIONS AMONG SIMILARLY SITUATED ORGANIZATIONS. THE BOARD WILL KEEP ROBUST MINUTES OF ITS DELIBERATIONS AND DECISIONS, THE PRESIDENT'S REPORTS, THE CORPORATE TREASURER'S REPORTS, AND ANY OTHER SUPPORTING DOCUMENTATION THAT IT RELIES ON FOR ITS COMPENSATION DECISIONS. ALL THESE DOCUMENTS WILL BE DELIVERED TO THE CORPORATE SECRETARY PROMPTLY AFTER THE BOARD MEETING FOR ENTRY INTO THE CORPORATE BOOKS AND RECORDS. THE PROCESS DESCRIBED HERE WAS LAST COMPLETED IN 2023.
FORM 990, PART VI, SECTION C, LINE 19THE GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS ARE MADE AVAILABLE TO THE PUBLIC ON THE ORGANIZATION'S WEBSITE AND UPON REQUEST.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp

Disregarded Entity Name DisregardedEntityName

FieldValueIRS element (for citing)
Business Name Line1JAEB CENTER RESEARCH TRUST INCBusinessNameLine1Txt

US Address USAddress

FieldValueIRS element (for citing)
Address Line115310 AMBERLY DRIVEAddressLine1Txt
CityTAMPACityNm
State AbbreviationFLStateAbbreviationCd
ZIP33647ZIPCd
FieldValueIRS element (for citing)
EIN270717710EIN
Primary ActivitiesSUPPORTPrimaryActivitiesTxt
Legal Domicile StateFLLegalDomicileStateCd
Exempt Code Section501(C)(3)ExemptCodeSectionTxt
Public Charity StatusLINE 12B, IIPublicCharityStatusTxt
Direct Controlling NAN/ADirectControllingNACd
Controlled Organization0ControlledOrganizationInd
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts Rylts0ReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgYes (1)GiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgYes (1)GiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other Org0LoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth Org0LoansOrGuaranteesFromOthOrgInd
Div Related Organization0DivRelatedOrganizationInd
Asset Sale To Other Org0AssetSaleToOtherOrgInd
Asset Purchase From Other Org0AssetPurchaseFromOtherOrgInd
Asset Exchange0AssetExchangeInd
Rental Of Facilities To Oth Org0RentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth Org0RentalOfFcltsFromOthOrgInd
Perform Of Services For Oth Org0PerformOfServicesForOthOrgInd
Perform Of Services By Other Org0PerformOfServicesByOtherOrgInd
Sharing Of FacilitiesYes (1)SharingOfFacilitiesInd
Paid Employees SharingYes (1)PaidEmployeesSharingInd
Reimbursement Paid To Other Org0ReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other Org0ReimbursementPaidByOtherOrgInd
Transfer To Other Org0TransferToOtherOrgInd
Transfer From Other Org0TransferFromOtherOrgInd

Transactions Related Org TransactionsRelatedOrgGrp (2 entries)

Transaction TypeTransactionTypeTxtInvolvedInvolvedAmtMethod Of Amount DeterminationMethodOfAmountDeterminationTxt
JAEB CENTER RESEARCH TRUST INC
B$911,714CASH
JAEB CENTER RESEARCH TRUST INC
C$6,177,957CASH

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.